Stock comparison
AGILENT TECHNOLOGIES, INC. is 6.9x more valuable than 10x Genomics, Inc. by market capitalization ($37.75 B vs $5.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
A is larger
AGILENT TECHNOLOGIES, INC. is 6.9x more valuable than 10x Genomics, Inc. by market capitalization ($37.75 B vs $5.50 B).
Market value leader
A
AGILENT TECHNOLOGIES, INC. is 6.9x more valuable than 10x Genomics, Inc. by market capitalization ($37.75 B vs $5.50 B).
Revenue leader
A
TXG: $642.82M vs A: $6.95B.
Profit leader
A
TXG: -$43.50M vs A: $1.30B.
Margin leader
A
TXG: -6.8% vs A: 18.8% net margin.
| Metric | TXG | A |
|---|---|---|
| Market cap | $5.50 B | $37.75 B |
| US-listed rank | #1345 | #404 |
| Revenue (latest FY) | $642.82M | $6.95B |
| Net income (latest FY) | -$43.50M | $1.30B |
| Net margin | -6.8% | 18.8% |
| P/E (trailing FY) | - | 29.0x |
| SEC filings | 652 | 2,339 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AGILENT TECHNOLOGIES, INC. is 6.9x more valuable than 10x Genomics, Inc. by market capitalization ($37.75 B vs $5.50 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: 10x Genomics, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.